Lucian Iancovici is a Principal with TPG Growth based in San Francisco, where he focuses on healthcare investing. Prior to joining TPG, Lucian was a GP at dRx Capital and led the Qualcomm Life Fund. Among the investments Lucian led or co-led are Edico Genome (acquired by Illumina) and Fitbit. Previously, Lucian worked at McKinsey & Company, where he worked in the North American healthcare practice advising on clinical- and business-model transformation for large hospital systems. Lucian is a board certified internal medicine doctor and practiced in New York prior to joining McKinsey and Company. Lucian trained in internal medicine at Columbia University Medical Center and completed both medical school and undergraduate studies at Tufts University.